NDAORALTABLET
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
25
Mechanism of Action
P2Y 12 class of ADP receptors on platelets.
Indications (8)
Clinical Trials (5)
MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)
Started May 2022
12 enrolled
End-Stage Renal DiseaseKidney Failure, Chronic
Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI
Started Dec 2020
1,000 enrolled
Coronary Artery DiseaseMyocardial IschemiaMyocardial Infarction+1 more
Drug Interaction Study of MGL-3196 With Clopidogrel
Started Jul 2019
20 enrolled
Healthy
Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome
Started Jul 2019
1,900 enrolled
Acute Coronary Syndromes
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
Started Jan 2019
2,366 enrolled
Acute Ischemic StrokeTransient Ischemic Attack (TIA)